— Know what they know.
Not Investment Advice
Also trades as: CRY (NYSE) · $vol 4M

AORT NYSE

Artivion, Inc.
1W: -0.8% 1M: -38.6% 3M: -40.6% YTD: -48.8% 1Y: -22.0% 3Y: +54.5% 5Y: -21.5%
$22.46
-0.31 (-1.36%)
 
Weekly Expected Move ±15.2%
$16 $19 $23 $26 $30
NYSE · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 32 · $1.1B mcap · 46M float · 1.22% daily turnover · Short 71% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$441M +13.6% ▲
5Y CAGR: +11.8%
Gross Profit
$270M +8.7% ▲
5Y CAGR: +10.0%
Operating Income
$27M -31.2% ▼
5Y CAGR: +61.4%
Net Income
$10M +173.1% ▲
EPS (Diluted)
$0.21 +165.6% ▲
EBITDA
$49M -3.5% ▼
5Y CAGR: +19.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$299M$314M$354M$389M$441M
YoY Growth+18.0%+5.0%+12.8%+9.8%+13.6%
Cost of Revenue$101M$111M$125M$140M$171M
Gross Profit$198M$203M$229M$249M$270M
Gross Margin66.1%64.5%64.7%64.0%61.3%
R&D Expenses$36M$39M$29M$28M$31M
SG&A Expenses$170M$157M$209M$192M$213M
Operating Expenses$189M$196M$223M$210M$244M
Operating Income$8M$6M$6M$39M$27M
Operating Margin2.7%2.0%1.6%10.0%6.1%
Interest Expense$17M$18M$25M$34M$27M
Income Before Tax-$15M-$15M-$22M-$8M$15M
Tax Expense$7K$4M$9M$6M$5M
Net Income-$15M-$19M-$31M-$13M$10M
Net Margin-5.0%-6.1%-8.7%-3.4%2.2%
EPS (Diluted)$-0.38$-0.48$-0.75$-0.32$0.21
EBITDA$26M$26M$27M$51M$49M
Shares Outstanding39M40M41M42M47M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms